It has been previously observed that use of TNF inhibitor can alleviate depressive symptoms for treatment-resistant MDD patients with elevated inflammatory markers7, and the anti-inflammatory medications such as cyclooxygenase-2 inhibitor celecoxib exhibited a satisfactory therapeutic effect in patients with MDD8. This evidence concerns the gene TNF and major depressive disorder.